
Twist Bioscience Corporation TWST
$ 48.84
-6.96%
Quarterly report 2025-Q4
added 02-02-2026
Twist Bioscience Corporation DIO Ratio 2011-2026 | TWST
Annual DIO Ratio Twist Bioscience Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 | 57 | 83.8 | 109 | 99.8 | 58.3 | 56.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 109 | 51.5 | 73.7 |
Quarterly DIO Ratio Twist Bioscience Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.2 | - | 47.7 | 43.3 | 47.3 | - | 58.1 | 62.9 | 67.5 | - | 83.2 | 92.5 | 130 | 42.8 | 129 | 130 | 121 | 41.6 | 116 | 108 | 64.6 | 25.6 | 68.1 | 49.5 | 48.8 | 19.1 | 58.7 | 42.6 | 44.6 | 23.8 | 73.3 | 23.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 130 | 19.1 | 66.2 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M | ||
|
Trinity Biotech plc
TRIB
|
212 | $ 0.73 | -1.86 % | $ 61.9 M | ||
|
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | ||
|
Burning Rock Biotech Limited
BNR
|
243 | $ 29.0 | -3.07 % | $ 316 M | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
245 | $ 1.14 | -2.16 % | $ 1.45 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
304 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
92.9 | $ 210.56 | -0.33 % | $ 154 B | ||
|
Castle Biosciences
CSTL
|
48.7 | $ 29.41 | -6.17 % | $ 817 M | ||
|
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | ||
|
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 202.21 | -0.11 % | $ 22.4 B | ||
|
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | ||
|
DexCom
DXCM
|
115 | $ 73.08 | 1.11 % | $ 28.5 B | ||
|
DarioHealth Corp.
DRIO
|
165 | $ 11.75 | 2.8 % | $ 333 M | ||
|
CareDx, Inc
CDNA
|
48.3 | $ 18.83 | -5.23 % | $ 1.01 B | ||
|
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | ||
|
Illumina
ILMN
|
137 | $ 117.53 | -2.06 % | $ 18.7 B | ||
|
Fulgent Genetics
FLGT
|
7.17 | $ 23.18 | -0.39 % | $ 701 M | ||
|
Exact Sciences Corporation
EXAS
|
60.9 | $ 103.45 | 0.15 % | $ 19.5 B | ||
|
Lantheus Holdings
LNTH
|
44.2 | $ 74.31 | 1.54 % | $ 5.14 B | ||
|
Guardant Health
GH
|
82.1 | $ 103.36 | -2.84 % | $ 13 B | ||
|
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
0.213 | $ 99.61 | 1.22 % | $ 8.22 B | ||
|
Interpace Biosciences
IDXG
|
26.2 | $ 1.85 | 2.78 % | $ 8.12 M | ||
|
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B | ||
|
Charles River Laboratories International
CRL
|
35.3 | $ 169.68 | 3.11 % | $ 8.41 B | ||
|
IDEXX Laboratories
IDXX
|
91.6 | $ 635.6 | 0.77 % | $ 52.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 31.19 | 0.73 % | $ 20 B | ||
|
Quidel Corporation
QDEL
|
133 | $ 22.47 | -4.85 % | $ 947 M | ||
|
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 283.38 | 0.32 % | $ 23.8 B | ||
|
Biomerica
BMRA
|
147 | $ 2.17 | -2.25 % | $ 4.98 M | ||
|
Bioventus
BVS
|
175 | $ 8.57 | -0.06 % | $ 537 M | ||
|
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
79 | $ 1 378.44 | 0.14 % | $ 28.4 B |